Layla Hosseini-Gerami

Dr. Layla Hosseini-Gerami bridges the worlds of chemistry, biology, and AI in her role as Chief Data Science Officer at Ignota Labs. She earned a PhD at the University of Cambridge in which she pioneered integrative cheminformatics and bioinformatics strategies for understanding drug molecular mechanisms, winning the Chemistry Theory Outstanding Thesis Award in 2023, and producing several publications in collaboration with Eli Lilly. At Ignota Labs, her goal is to leverage AI not just to understand, but also to prevent adverse drug reactions, ensuring safer therapeutic options for patients.